NX1 Reinstated to Official Quotation on ASX
Key points
- Trading in NX1 securities resumes post-announcement
- Announcement relates to existing debt facility
- Issued by ASX Compliance
Full summary
Nexalis Therapeutics Ltd (NX1) has announced that trading in its securities will be reinstated on the Australian Securities Exchange (ASX) immediately following the release of an announcement concerning its existing debt facility. This reinstatement follows a temporary suspension of trading. The announcement was issued by ASX Compliance.
Summary generated by a large language model. Please interpret with care.